AZD9291DA HCl salt

WARNING: This product is for research use only, not for human or veterinary use.

Description:AZD9291-DA is a des acryl analogue of AZD9291, which is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. AZD9291 is highly active in preclinical models and is well tolerated in animal models. It inhibits both activating and resistant EGFR mutations while sparing the normal form of EGFR that is present in normal skin and gut cells, thereby reducing the side effects encountered with currently available medicines.

Price and Availability

AZD9291DA HCl salt, purity > 98%, is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Chemical Structure

Theoretical Analysis

MedKoo Cat#: 206042AName: AZD9291DA HCl saltCAS#: 1421372-66-8Chemical Formula: C25H31N7OExact Mass: 445.25901Molecular Weight: 445.56Elemental Analysis: C, 67.39; H, 7.01; N, 22.01; O, 3.59

Synonym:AZD9291DA HCl salt; AZD9291 DA; AZD9291-DA; AZD9291-DA hydrochloride

IUPAC/Chemical Name:N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine hydrochloride

InChi Key:HTNTZPBKKCORTP-UHFFFAOYSA-N

InChi Code:InChI=1S/C25H31N7O/c1-30(2)12-13-31(3)23-15-24(33-5)21(14-19(23)26)29-25-27-11-10-20(28-25)18-16-32(4)22-9-7-6-8-17(18)22/h6-11,14-16H,12-13,26H2,1-5H3,(H,27,28,29)

SMILES Code:NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C

Technical Data

References

1: Targeting resistance in lung cancer. Cancer Discov.2013 Dec;3(12):OF9. doi: 10.1158/2159-8290.CD-ND2013-025. Epub 2013 Nov 7. PubMed PMID: 24327718.